Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02422147 · ClinicalTrials.gov registry record
EUS-guided Ablation of Pancreatic Cyst Neoplasms
A clinical trial, sponsored by AdventHealth.
- Completed
- Registry status
- 1,000
- Enrollment target
NCT02422147: Completed study, sponsored by AdventHealth.
NCT02422147 is a clinical trial that has completed, run by AdventHealth. The registered enrollment target is 1,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02422147 has completed, sponsored by AdventHealth.
- COMPLETED
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
This is a registry that will maintain prospective data on the clinical outcomes of all patients with pancreatic cyst lesions who undergo EUS-guided alcohol ablation.
Primary Outcome
Clinical outcomes
Interventions
- PROCEDURE Ablation of PCL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2016-06-01 |
| Est. Completion | 2024-12-12 |
What the finished NCT02422147 record still lists
NCT02422147 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Ablation of PCL is the first listed.
NCT02422147 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02422147 about?
NCT02422147 is a clinical study titled "EUS-guided Ablation of Pancreatic Cyst Neoplasms". This is a registry that will maintain prospective data on the clinical outcomes of all patients with pancreatic cyst lesions who undergo EUS-guided alcohol ablation.
What is the current status of trial NCT02422147?
This trial is currently completed. The enrollment target is 1,000 participants. The study started on 2016-06-01. Estimated completion is 2024-12-12.
What interventions are being tested in trial NCT02422147?
The interventions under investigation include: Ablation of PCL (PROCEDURE).
Who is sponsoring clinical trial NCT02422147?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI